[artículo] 
inThe British Journal of Psychiatry > Año 2017 - Vol.210 - No.6 (Junio) . - pp.422-428

Título :	Ketamine as the anaesthetic for electroconvulsive therapy: : the KANECT randomised controlled trial
Tipo de documento:	texto impreso
Autores:	Fernie, Gordon, Autor ; Currie, James, Autor ; Perrin, Jennifer S., Autor
Fecha de publicación:	2017
Artículo en la página:	pp.422-428
Idioma :	Inglés (eng)
Palabras clave:	Ketamina, Terapia electroconvulsiva, Severidad de la depresión.
Resumen:	Ketamine has recently become an agent of interest as an acute treatment for severe depression and as the anaesthetic for electroconvulsive therapy (ECT). Subanaesthetic doses result in an acute reduction in depression severity while evidence is equivocal for this antidepressant effect with anaesthetic or adjuvant doses.
Link:	./index.php?lvl=notice_display&id=61

[artículo] Ketamine as the anaesthetic for electroconvulsive therapy: : the KANECT randomised controlled trial [texto impreso] / Fernie, Gordon, Autor ; Currie, James, Autor ; Perrin, Jennifer S., Autor . - 2017 . - pp.422-428.
Idioma : Inglés (eng)
in The British Journal of Psychiatry > Año 2017 - Vol.210 - No.6 (Junio) . - pp.422-428

Palabras clave:	Ketamina, Terapia electroconvulsiva, Severidad de la depresión.
Resumen:	Ketamine has recently become an agent of interest as an acute treatment for severe depression and as the anaesthetic for electroconvulsive therapy (ECT). Subanaesthetic doses result in an acute reduction in depression severity while evidence is equivocal for this antidepressant effect with anaesthetic or adjuvant doses.
Link:	./index.php?lvl=notice_display&id=61